AI-Assisted MOA Discovery in Action
See how leading biotech companies are accelerating drug discovery with Embyr's integrated platform.
Metabolic Disease
Acme Bio
Accelerating Target Discovery for MASH Under Partner Pressure
5 compounds analyzed → 3 leads prioritized in 14 weeks
Virtual Cell Validation
Darwin AI
Computational predictions require wet-lab confirmation
$200M program rescued — root cause identified in 14 weeks
